This report is based on a survey of 360 senior life sciences industry executives as well as interviews with business leaders, regulators, and academics.
This article will help you think through ways to effectively apply externally-sourced, patient-level data to inform decisions along the product lifecycle.
Life sciences companies are carrying new operational and scientific risk as they expand their product portfolios in the face of scientific uncertainty.